Analyst Coverage
The analysts at the investment and securities firms listed below currently write research reports on GW Pharmaceuticals plc. Please note that this list is subject to change and that any estimates, forecasts or opinions are made by the analysts alone and do not represent the estimates, forecasts or opinions of GW or its management. By distributing the information below, GW does not imply its endorsement of or concurrence with such information. GW does not accept any responsibility whatsoever for the views of these or any other analysts reporting on the company.
Edison Investment Research
Robin Davison
Tel: +44 (0)20 3077 5700
http://www.edisoninvestmentresearch.co.uk
- Click here for Edison research – 03.06.10
- Click here for Edison research – 25.03.10
- Click here for Edison research – 19.03.10
- Click here for Edison research – 26.11.09
Edison's GW company profile page : http://www.edisoninvestmentresearch.co.uk/research/company/GW-Pharmaceuticals
(access requires free registration)
Execution Noble
Stefan Hamill
Tel: +44 (0)20 7763 2200
http://www.execution-noble.com
Investec Securities
Andrew Jones
Tel: +44 (0)20 7597 5000
KBC Peel Hunt
Paul Cuddon
Tel: +44 (0)20 7418 8900
Nomura Code Securities
Samir Devani
Tel: +44 (0) 207 776 1244
Piper Jaffray
Richard Parkes
+44 (0)20 3142 8744
Michael Aitkenhead
+44 (0)20 3142 8704
Singer Capital Markets Limited
Shawn Manning
Tel: +44 (0) 20 3205 7500